The latest advancements and strategies in immunotherapy are as follows. PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors, such as nivolumab in combination with ipilimumab, and tremelimumab plus ...
Data were summarized with the search of 'colorectal' and 'antibody' as of August 2012 at ClinicalTrials.gov [202]. EGFR: EGF receptor; mAb: Monoclonal antibody; VEGFR: VEGF receptor. The authors ...